LuciElafib 80 MG (Elafibranor)

Description

Elafibranor 80mg

Each film-coated tablet contains: Elafibranor………………………………80mg.

INDICATION

LuciElafib is a peroxisome proliferator -activated receptor (PPAR) agonist indicated for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults who have an inadequate response to UDCA, or as monotherapy in patients unable to tolerate UDCA.

DOSAGE AND USE

The recommended dosage is 80 mg orally once daily with or without food.

STORAGE

In a dry place and store at 20℃ to 25℃.

MANUFACTURED AND MARKETED BY

LUCIUS PHARMACEUTICALS(LAO) CO., LTD No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos

WARNING

Keep medicine out of reach of Children. Do not administer LuciElafib during Pregnancy and Lactation.

PLEASE SEE PACKAGE INSERT